NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/12/2026
Back to search
Official data from USPTO
FILLDERM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
02/13/2026
Trademark type
Combined
Nice classes
5
Filing date
04/12/2022
Registration date
10/31/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/31/2023
Last transaction
02/13/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
98
Owner location
CY
Examiner
LOZEAU, BRANDON THOMAS
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "FILLDERM" to the right of a circular design comprised of smaller circles and asymmetrical cell shapes, all in teal.
Holders and representatives
Holders
DATAZI PHARMA LTD
Representatives
William S. Fultz Womble Bond Dickinson (US) LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for use in dermatology; injectable preparations for medical and pharmaceutical purposesinjectable dermal fillers; pharmaceutical preparations made from hyaluronic acid for use in dermatology; pharmaceutical preparations made from lidocaine for use in dermatology; injectable preparations made from lidocaine for use as local anesthetics; injectable preparations made from hyaluronic acid for use in dermatology; filled syringes sold filled with pharmaceutical preparations made from lidocaine and hyaluronic acid for medical purposes; pre-filled syringes sold filled with pharmaceutical preparations made from lidocaine and hyaluronic acid for medical purposes
Publications
History of USPTO decisions and trademark events.
30 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/09/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/26/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/02/2024
FIMP
FINAL DISPOSITION PROCESSED
02/02/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/31/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/12/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/31/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
10/31/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/25/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
10/25/2023
GPNX
NOTIFICATION PROCESSED BY IB
08/20/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/15/2023
PUBO
PUBLISHED FOR OPPOSITION
08/15/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/02/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/02/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/26/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/07/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/30/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/30/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/30/2023
RFNT
REFUSAL PROCESSED BY IB
04/19/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/28/2023
RFRR
REFUSAL PROCESSED BY MPU
03/28/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/01/2023
CNRT
NON-FINAL ACTION WRITTEN
01/31/2023
DOCK
ASSIGNED TO EXAMINER
01/30/2023
MAFR
APPLICATION FILING RECEIPT MAILED
05/27/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/23/2022
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
05/19/2022
Continuous trademark protection
Get notified about every new filing that threatens FILLDERM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.